Robert H. Lurie Comprehensive Cancer Center

Clinical research site in Chicago, Illinois · 250 E SUPERIOR ST, SUITE 520, CHICAGO, IL 60611-2914 · (312) 472-5823 · Website

5.0on Google· View on Google Maps

As of September 2026, 12 paid clinical trials are recruiting at Robert H. Lurie Comprehensive Cancer Center in Chicago, Illinois. Active studies at this site cover conditions such as PIK3CA Mutation, HER2- Negative Breast Cancer and Hormone Receptor Positive Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

New trial at Robert H. Lurie Comprehensive Cancer Center? We'll email you when one opens.

Recruiting clinical trials at Robert H. Lurie Comprehensive Cancer Center (12)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for PIK3CA Mutation

52 locations incl. Gilbert

Sponsor: Relay Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06982521·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for AML

36 locations incl. Gilbert

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT06001788·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for Acute Myeloid Leukemia

44 locations incl. Phoenix

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT05735184·Phase 1·Recruiting·Listed Feb 2023

Apply to this trial

A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

for Extensive Stage-small Cell Lung Cancer

25 locations incl. Birmingham

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06362252·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

for Lymphoma

14 locations incl. Aurora

Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All·Age: 18+

Code: NCT07015242·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

for Ovarian Cancer

12 locations incl. Duarte

Sponsor: Regeneron Pharmaceuticals

Sex: Female·Age: 18+

Code: NCT04590326·Phase 1, Phase 2·Recruiting·Listed Oct 2020

Apply to this trial

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

for Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen

22 locations incl. Los Angeles

Sponsor: Servier Bio-Innovation LLC

Sex: All·Age: 18+

Code: NCT06127407·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

for Relapsed or Resistant Acute Leukaemias

5 locations incl. Tampa

Sponsor: Lin BioScience, Inc

Sex: All·Age: 18 - 120

Code: NCT05756322·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

for Breast Cancer Early Stage Breast Cancer (Stage 1-3)

2 locations in Chicago

Sponsor: University of Illinois at Chicago

Sex: Female·Age: 25 - 99

Code: NCT07387445·Recruiting·Listed Feb 2026

Apply to this trial

Luspatercept + Darbepoetin in MDS

for MDS (Myelodysplastic Syndrome)

4 locations incl. New Haven

Sponsor: Yale University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07096297·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

for Prostate Cancer

35 locations incl. Tuscaloosa

Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male·Age: 21+

Code: NCT03151629·Recruiting·Listed May 2017

Apply to this trial

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

for Essential Thrombocythemia

40 locations incl. Gilbert

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT07623200·Phase 3·Recruiting·Listed Jun 2026

Apply to this trial

Get new-trial alerts for Robert H. Lurie Comprehensive Cancer Center

We'll email you whenever a new clinical trial starts recruiting at this research site in Chicago, IL. Unsubscribe anytime.

More research sites in Chicago

Northwestern University (334 trials)
University of Chicago (186 trials)
Rush University Medical Center (158 trials)
Ann & Robert H. Lurie Children's Hospital of Chicago (111 trials)
University of Chicago Medical Center (98 trials)
University of Chicago Comprehensive Cancer Center (86 trials)
University of Illinois (83 trials)
Northwestern Memorial Hospital (81 trials)
University of Illinois at Chicago (71 trials)
Advocate Illinois Masonic Medical Center (47 trials)

Is this your research site?

This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.

Explore more

Paid clinical trials in Chicago, IL · Illinois clinical trials